Sandoval J, Esteller M: Cancer epigenomics: beyond genomics. Curr Opin Genet Dev. 2012, 22: 50-55. 10.1016/j.gde.2012.02.008.
CAS
PubMed
Google Scholar
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005, 352: 997-1003. 10.1056/NEJMoa043331.
CAS
PubMed
Google Scholar
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach CL, Silverman LR: Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. The Lancet Oncology. 2009, 10: 223-232. 10.1016/S1470-2045(09)70003-8.
PubMed Central
CAS
PubMed
Google Scholar
Baylin SB, Jones PA: A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011, 11: 726-734. 10.1038/nrc3130.
PubMed Central
CAS
PubMed
Google Scholar
Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996, 56: 3630-3633.
CAS
PubMed
Google Scholar
Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang WW, Kim MM, Claybourne Q, Goldenberg D, Khan Z, Khan T, Westra WH, Sidranksy D, Koch W, Califano JA: Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011, 17: 4782-4789. 10.1158/1078-0432.CCR-11-0324.
PubMed Central
CAS
PubMed
Google Scholar
Sinha P, Bahadur S, Thakar A, Matta A, Macha M, Ralhan R, Gupta SD: Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck. 2009, 31: 1423-1430. 10.1002/hed.21122.
PubMed
Google Scholar
Huang KH, Huang SF, Chen IH, Liao CT, Wang HM, Hsieh LL: Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma. Clin Cancer Res. 2009, 15: 4174-4180. 10.1158/1078-0432.CCR-08-2929.
CAS
PubMed
Google Scholar
Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Penuela JM, Boffetta P, Merletti F: Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer. 2007, 110: 1745-1751. 10.1002/cncr.22975.
CAS
PubMed
Google Scholar
Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D: Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001, 61: 939-942.
CAS
PubMed
Google Scholar
Kristensen LS, Hansen LL: PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem. 2009, 55: 1471-1483. 10.1373/clinchem.2008.121962.
CAS
PubMed
Google Scholar
Brandes JC, Carraway H, Herman JG: Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter. Oncogene. 2007, 26: 6229-6237. 10.1038/sj.onc.1210433.
CAS
PubMed
Google Scholar
Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK: Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008, 14: 2664-2672. 10.1158/1078-0432.CCR-07-1232.
CAS
PubMed
Google Scholar
Mikeska T, Candiloro IL, Dobrovic A: The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics. 2010, 2: 561-573. 10.2217/epi.10.32.
CAS
PubMed
Google Scholar
Wojdacz TK: The limitations of locus specific methylation qualification and quantification in clinical material. Front Genet. 2012, 3: 21-
PubMed Central
PubMed
Google Scholar
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996, 93: 9821-9826. 10.1073/pnas.93.18.9821.
PubMed Central
CAS
PubMed
Google Scholar
Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM: Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol. 2011, 32: 528-536.
CAS
PubMed
Google Scholar
Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY: Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev. 2004, 13: 150-156. 10.1158/1055-9965.EPI-082-3.
CAS
PubMed
Google Scholar
Lima LM, de Souza LR, da Silva TF, Pereira CS, Guimaraes AL, de Paula AM, de Andrade CH: DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors. Histopathology. 2012, 60: 489-496. 10.1111/j.1365-2559.2011.04062.x.
PubMed
Google Scholar
Szaumkessel M, Richter J, Giefing M, Jarmuz M, Kiwerska K, Tonnies H, Grenman R, Heidemann S, Szyfter K, Siebert R: Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma. Int J Oncol. 2011, 39: 505-514.
CAS
PubMed
Google Scholar
Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z: Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Dis. 2011, 17: 794-800. 10.1111/j.1601-0825.2011.01838.x.
CAS
PubMed
Google Scholar
Gao S, Eiberg H, Krogdahl A, Liu CJ, Sorensen JA: Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. J Oral Pathol Med. 2005, 34: 116-119. 10.1111/j.1600-0714.2004.00275.x.
CAS
PubMed
Google Scholar
Tsunematsu T, Kudo Y, Iizuka S, Ogawa I, Fujita T, Kurihara H, Abiko Y, Takata T: RUNX3 has an oncogenic role in head and neck cancer. PLoS One. 2009, 4: e5892-10.1371/journal.pone.0005892.
PubMed Central
PubMed
Google Scholar
Worsham MJ, Chen KM, Meduri V, Nygren AO, Errami A, Schouten JP, Benninger MS: Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006, 132: 668-677. 10.1001/archotol.132.6.668.
PubMed
Google Scholar
Chang HW, Chow V, Lam KY, Wei WI, Yuen A: Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer. 2002, 94: 386-392. 10.1002/cncr.10211.
CAS
PubMed
Google Scholar
Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ, Reibel J, Dabelsteen E: Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer. 2004, 109: 230-237. 10.1002/ijc.11592.
CAS
PubMed
Google Scholar
Supic G, Kozomara R, Brankovic-Magic M, Jovic N, Magic Z: Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol. 2009, 45: 1051-1057. 10.1016/j.oraloncology.2009.07.007.
CAS
PubMed
Google Scholar
Gao S, Bennett EP, Reibel J, Chen X, Christensen ME, Krogdahl A, Dabelsteen E: Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma–genotypic and phenotypic characterization. APMIS. 2004, 112: 11-20. 10.1111/j.1600-0463.2004.apm1120103.x.
PubMed
Google Scholar
Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z: Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Oral Oncol. 2011, 47: 702-708. 10.1016/j.oraloncology.2011.05.014.
CAS
PubMed
Google Scholar
Stephen JK, Chen KM, Shah V, Havard S, Kapke A, Lu M, Benninger MS, Worsham MJ: DNA hypermethylation markers of poor outcome in laryngeal cancer. Clin Epigenetics. 2010, 1: 61-69. 10.1007/s13148-010-0005-3.
PubMed Central
CAS
PubMed
Google Scholar
Rigi-Ladiz MA, Kordi-Tamandani DM, Torkamanzehi A: Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma. Clin Epigenetics. 2011, 3: 6-10.1186/1868-7083-3-6.
PubMed Central
CAS
PubMed
Google Scholar
Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N: Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer. DNA Cell Biol. 2011, 30: 17-24. 10.1089/dna.2010.1090.
CAS
PubMed
Google Scholar
Bolt J, Vo QN, Kim WJ, McWhorter AJ, Thomson J, Hagensee ME, Friedlander P, Brown KD, Gilbert J: The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms. Oral Oncol. 2005, 41: 1013-1020. 10.1016/j.oraloncology.2005.06.003.
CAS
PubMed
Google Scholar
Shaw RJ, Hall GL, Lowe D, Liloglou T, Field JK, Sloan P, Risk JM: The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression. Arch Otolaryngol Head Neck Surg. 2008, 134: 251-256. 10.1001/archoto.2007.50.
PubMed
Google Scholar
Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT: Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004, 23: 1000-1004. 10.1038/sj.onc.1207256.
CAS
PubMed
Google Scholar
Maruya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R, El-Naggar AK: Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res. 2004, 10: 3825-3830. 10.1158/1078-0432.CCR-03-0370.
CAS
PubMed
Google Scholar
Shaw R, Hobkirk A, Nikolaidis G, Woolgar JA, Triantafyllou A, Brown JS, Liloglou T, Risk JM: Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. Ann Surg Oncol. 2013, 20: 2796-2802. 10.1245/s10434-012-2713-8.
PubMed
Google Scholar
Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, Camargo AA, Caballero OL, Tajara EH, Cordeiro JA, Rahal P: Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet. 2007, 173: 31-37. 10.1016/j.cancergencyto.2006.09.008.
CAS
PubMed
Google Scholar
Marsit CJ, Posner MR, McClean MD, Kelsey KT: Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer. 2008, 113: 1566-1571. 10.1002/cncr.23770.
PubMed Central
PubMed
Google Scholar
De Schutter H, Geeraerts H, Verbeken E, Nuyts S: Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. Oncol Rep. 2009, 21: 507-513.
CAS
PubMed
Google Scholar
Steinmann K, Sandner A, Schagdarsurengin U, Dammann RH: Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep. 2009, 22: 1519-1526.
CAS
PubMed
Google Scholar
Kordi-Tamandani DM, Moazeni-Roodi AK, Rigi-Ladiz MA, Hashemi M, Birjandian E, Torkamanzehi A: Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. Arch Oral Biol. 2010, 55: 809-814. 10.1016/j.archoralbio.2010.06.017.
CAS
PubMed
Google Scholar
Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T: The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer. 2001, 93: 667-673. 10.1002/ijc.1386.
CAS
PubMed
Google Scholar
Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM: Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer. 2006, 94: 561-568. 10.1038/sj.bjc.6602972.
PubMed Central
CAS
PubMed
Google Scholar
Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT: Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002, 21: 4231-4236. 10.1038/sj.onc.1205528.
CAS
PubMed
Google Scholar
Su PF, Huang WL, Wu HT, Wu CH, Liu TY, Kao SY: p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Oral Oncol. 2010, 46: 734-739. 10.1016/j.oraloncology.2010.07.002.
CAS
PubMed
Google Scholar
Viswanathan M, Tsuchida N, Shanmugam G: Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer. 2003, 105: 41-46. 10.1002/ijc.11028.
CAS
PubMed
Google Scholar
Weiss D, Basel T, Sachse F, Braeuninger A, Rudack C: Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation. Mol Carcinog. 2011, 50: 680-688. 10.1002/mc.20798.
CAS
PubMed
Google Scholar
Sasiadek MM, Stembalska-Kozlowska A, Smigiel R, Ramsey D, Kayademir T, Blin N: Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer. 2004, 90: 1594-1599. 10.1038/sj.bjc.6601679.
PubMed Central
CAS
PubMed
Google Scholar
Wong TS, Man MWL, Lam AKY, Wei WI, Kwong YL, Yuen APW: The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer. 2003, 39: 1881-1887. 10.1016/S0959-8049(03)00428-3.
CAS
PubMed
Google Scholar
Puri SK, Si L, Fan CY, Hanna E: Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol. 2005, 26: 12-17. 10.1016/j.amjoto.2004.06.007.
CAS
PubMed
Google Scholar
Kato K, Hara A, Kuno T, Mori H, Yamashita T, Toida M, Shibata T: Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol. 2006, 132: 735-743. 10.1007/s00432-006-0122-8.
CAS
PubMed
Google Scholar
Taioli E, Ragin C, Wang XH, Chen J, Langevin SM, Brown AR, Gollin SM, Garte S, Sobol RW: Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer. 2009, 9: 354-10.1186/1471-2407-9-354.
PubMed Central
PubMed
Google Scholar
Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, Ralhan R: Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer. 2010, 127: 2367-2373. 10.1002/ijc.25377.
PubMed Central
CAS
PubMed
Google Scholar
Khor GH, Froemming GR, Zain RB, Abraham MT, Omar E, Tan SK, Tan AC, Vincent-Chong VK, Thong KL: DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Int J Med Sci. 2013, 10: 1727-1739. 10.7150/ijms.6884.
PubMed Central
CAS
PubMed
Google Scholar
O’Regan EM, Toner ME, Finn SP, Fan CY, Ring M, Hagmar B, Timon C, Smyth P, Cahill S, Flavin R, Sheils OM, O’Leary JJ: p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol. 2008, 39: 452-458. 10.1016/j.humpath.2007.08.004.
PubMed
Google Scholar
Lin SC, Chang KW, Chang CS, Liu TY, Tzeng YS, Yang FS, Wong YK: Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med. 2000, 29: 159-166. 10.1034/j.1600-0714.2000.290403.x.
CAS
PubMed
Google Scholar
Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, De-Paula AM, Gomez RS, Guimaraes AL: Effect of age on the association between p16CDKN2A methylation and DNMT3B polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010, 37: 167-176.
CAS
PubMed
Google Scholar
Martone T, Gillio-Tos A, De Marco L, Fiano V, Maule M, Cavalot A, Garzaro M, Merletti F, Cortesina G: Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res. 2007, 13: 5089-5094. 10.1158/1078-0432.CCR-07-0119.
CAS
PubMed
Google Scholar
Laytragoon-Lewin N, Chen F, Castro J, Elmberger G, Rutqvist LE, Lewin F, Turesson I, Lundgren J: DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients. Anticancer Res. 2010, 30: 4643-4648.
CAS
PubMed
Google Scholar
de Freitas C-SM, Stur E, Agostini LP, de Podesta JR, de Oliveira JC, Soares MS, Mendonca EF, Gouvea SA, Von Zeidler SV, Louro ID: Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep. 2012, 39: 10111-10119. 10.1007/s11033-012-1885-4.
Google Scholar
Gonzalez MV, Pello MF, Lopez-Larrea C, Suarez C, Menendez MJ, Coto E: Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol. 1997, 50: 509-512. 10.1136/jcp.50.6.509.
PubMed Central
CAS
PubMed
Google Scholar
Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, Kohama G, Tokino T: Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res. 2002, 8: 3164-3171.
CAS
PubMed
Google Scholar
Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S: Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev. 2008, 17: 414-420. 10.1158/1055-9965.EPI-07-0284.
CAS
PubMed
Google Scholar
Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000, 60: 892-895.
CAS
PubMed
Google Scholar
Shiga K, Ogawa T, Katagiri K, Yoshida F, Tateda M, Matsuura K, Kobayashi T: Differences between oral cancer and cancers of the pharynx and larynx on a molecular level. Oncol Lett. 2012, 3: 238-243.
PubMed Central
CAS
PubMed
Google Scholar
Wu CL, Roz L, McKown S, Sloan P, Read AP, Holland S, Porter S, Scully C, Paterson I, Tavassoli M, Thakker N: DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer. 1999, 25: 16-25. 10.1002/(SICI)1098-2264(199905)25:1<16::AID-GCC3>3.0.CO;2-2.
CAS
PubMed
Google Scholar
Paluszczak J, Misiak P, Wierzbicka M, Wozniak A, Baer-Dubowska W: Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol. 2011, 47: 104-107. 10.1016/j.oraloncology.2010.11.006.
CAS
PubMed
Google Scholar
Huang S, Lee H, Mar K, Ji D, Huang M, Hsia K: Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010, 109: 883-889. 10.1016/j.tripleo.2009.12.019.
PubMed
Google Scholar
Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG: Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia. Cancer Res. 1999, 59: 793-797.
CAS
PubMed
Google Scholar
Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY: O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004, 13: 967-975.
CAS
PubMed
Google Scholar
Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D: Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis. 2009, 15: 206-213. 10.1111/j.1601-0825.2008.01510.x.
CAS
PubMed
Google Scholar
Wang Y, Irish J, MacMillan C, Brown D, Xuan Y, Boyington C, Gullane P, Kamel-Reid S: High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 AND hMSH2. Int J Cancer. 2001, 93: 353-360. 10.1002/ijc.1337.
CAS
PubMed
Google Scholar
Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N: Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol. 2006, 17: 995-999. 10.1093/annonc/mdl048.
CAS
PubMed
Google Scholar
Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S: Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer. 2007, 109: 703-712. 10.1002/cncr.22430.
CAS
PubMed
Google Scholar
Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY: Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol. 2003, 12: 50-56. 10.1097/00019606-200303000-00007.
CAS
PubMed
Google Scholar
Gonzalez-Ramirez I, Ramirez-Amador V, Irigoyen-Camacho ME, Sanchez-Perez Y, Anaya-Saavedra G, Granados-Garcia M, Garcia-Vazquez F, Garcia-Cuellar CM: hMLH1 promoter methylation is an early event in oral cancer. Oral Oncol. 2011, 47: 22-26. 10.1016/j.oraloncology.2010.10.002.
CAS
PubMed
Google Scholar
Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F: Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer. 2002, 38: 1585-1592. 10.1016/S0959-8049(01)00422-1.
CAS
PubMed
Google Scholar
Gao F, Huang C, Lin M, Wang Z, Shen J, Zhang H, Jiang L, Chen Q: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol. 2009, 135: 739-747. 10.1007/s00432-008-0508-x.
CAS
PubMed
Google Scholar
Lee HW, Hwang YH, Han JH, Choi JH, Kang SY, Jeong SH, Ann MS, Oh YT, Kim JH, Kim CH, Sheen SS: High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer. Oral Oncol. 2010, 46: 209-213. 10.1016/j.oraloncology.2009.12.007.
CAS
PubMed
Google Scholar
Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC, Fouret P: Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. Clin Cancer Res. 2007, 13: 3855-3859. 10.1158/1078-0432.CCR-07-0252.
CAS
PubMed
Google Scholar
Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, Ahn YC, Jeong HS, Son YI, Baek JH, Park K: ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer. 2008, 99: 167-172. 10.1038/sj.bjc.6604464.
PubMed Central
CAS
PubMed
Google Scholar
Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, Stahel R, Sabatier L, Pignon JP, Tursz T, Le Chevalier T, Soria JC, Ialt Bio Investigators: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006, 355: 983-991. 10.1056/NEJMoa060570.
CAS
PubMed
Google Scholar
Do H, Wong NC, Murone C, John T, Solomon B, Mitchell PL, Dobrovic A: A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma. Sci Rep. 2014, 4: 4186-
PubMed Central
PubMed
Google Scholar
Cervigne NK, Machado J, Goswami RS, Sadikovic B, Bradley G, Perez-Ordonez B, Galloni NN, Gilbert R, Gullane P, Irish JC, Jurisica I, Reis PP, Kamel-Reid S: Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?. Hum Mol Genet. 2014, 23: 2618-2628. 10.1093/hmg/ddt657.
PubMed Central
CAS
PubMed
Google Scholar
Wolff E, Girod S, Liehr T, Vorderwülbecke U, Ries J, Steininger H, Gebhart E: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol. 1998, 34: 186-190. 10.1016/S1368-8375(97)00079-1.
CAS
PubMed
Google Scholar
Hecht F, Hecht BK: Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet. 1990, 46: 9-19. 10.1016/0165-4608(90)90003-S.
CAS
PubMed
Google Scholar
Lazar AD, Winter MR, Nogueira CP, Larson PS, Finnemore EM, Dolan RW, Fuleihan N, Chakravarti A, Zietman A, Rosenberg CL: Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res. 1998, 4: 2787-2793.
CAS
PubMed
Google Scholar
Lavin MF: The Mre11 complex and ATM: a two-way functional interaction in recognising and signaling DNA double strand breaks. DNA Repair (Amst). 2004, 3: 1515-1520. 10.1016/j.dnarep.2004.07.001.
CAS
Google Scholar
Lim AM, Young RJ, Collins M, Fox SB, McArthur GA, Corry J, Peters L, Rischin D, Solomon B: Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma. Oral Oncol. 2012, 48: 698-702. 10.1016/j.oraloncology.2012.02.014.
PubMed
Google Scholar
Joenje H, Arwert F: Connecting Fanconi anemia to BRCA1. Nat Med. 2001, 7: 406-407. 10.1038/86458.
CAS
PubMed
Google Scholar
Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, Thayer M, Cox B, Olson S, D’Andrea AD, Moses R, Grompe M: Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001, 7: 241-248. 10.1016/S1097-2765(01)00172-1.
CAS
PubMed
Google Scholar
Oksuzoglu B, Yalcin S: Squamous cell carcinoma of the tongue in a patient with Fanconi’s anemia: a case report and review of the literature. Ann Hematol. 2002, 81: 294-298. 10.1007/s00277-002-0455-6.
CAS
PubMed
Google Scholar
Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L: Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol. 2007, 43: 82-87. 10.1016/j.oraloncology.2006.01.007.
CAS
PubMed
Google Scholar
Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glockner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG: DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008, 358: 1118-1128. 10.1056/NEJMoa0706550.
CAS
PubMed
Google Scholar
Lim AM, Do H, Young RJ, Wong SQ, Angel C, Collins M, Takano EA, Corry J, Wiesenfeld D, Kleid S, Sigston E, Lyons B, Fox SB, Rischin D, Dobrovic A, Solomon B: Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome. Int J Cancer. 2014, 135: 887-895. 10.1002/ijc.28727.
CAS
PubMed
Google Scholar
Kristensen LS, Mikeska T, Krypuy M, Dobrovic A: Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res. 2008, 36: e42-10.1093/nar/gkn113.
PubMed Central
PubMed
Google Scholar
Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C: A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics. 2012, 7: 772-780. 10.4161/epi.20299.
PubMed Central
CAS
PubMed
Google Scholar
Wojdacz TK, Dobrovic A, Hansen LL: Methylation-sensitive high-resolution melting. Nat Protoc. 2008, 3: 1903-1908. 10.1038/nprot.2008.191.
CAS
PubMed
Google Scholar
Candiloro IL, Mikeska T, Dobrovic A: Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics. 2011, 6: 500-507. 10.4161/epi.6.4.14853.
PubMed Central
CAS
PubMed
Google Scholar
Liu Y, Ji Y, Qiu P: Identification of thresholds for dichotomizing DNA methylation data. EURASIP J Bioinform Syst Biol. 2013, 2013: 8-10.1186/1687-4153-2013-8.
PubMed Central
PubMed
Google Scholar
Cameron EE, Baylin SB, Herman JG: p15INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing. Blood. 1999, 94: 2445-2451.
CAS
PubMed
Google Scholar
Wee EJ, Rauf S, Shiddiky MJ, Dobrovic A, Trau M: DNA ligase-based strategy for quantifying heterogeneous DNA methylation without sequencing. Clin Chem. 2014
Google Scholar
Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Buhler A, Oakes CC, Larson RA, Kay NE, Jelinek DF, Kipps TJ, Rassenti LZ, Gribben JG, Dohner H, Heerema NA, Marcucci G, Plass C, Byrd JC: Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol. 2012, 30: 2483-2491. 10.1200/JCO.2011.39.3090.
PubMed Central
CAS
PubMed
Google Scholar
Pulling LC, Grimes MJ, Damiani LA, Juri DE, Do K, Tellez CS, Belinsky SA: Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer. Carcinogenesis. 2009, 30: 2023-2030. 10.1093/carcin/bgp276.
PubMed Central
CAS
PubMed
Google Scholar
Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, Fan JB, Shen R: High density DNA methylation array with single CpG site resolution. Genomics. 2011, 98: 288-295. 10.1016/j.ygeno.2011.07.007.
CAS
PubMed
Google Scholar
van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003, 17: 2257-2317. 10.1038/sj.leu.2403202.
CAS
PubMed
Google Scholar
Wojdacz TK, Dobrovic A: Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007, 35: e41-10.1093/nar/gkm013.
PubMed Central
PubMed
Google Scholar
Worm J, Aggerholm A, Guldberg P: In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem. 2001, 47: 1183-1189.
CAS
PubMed
Google Scholar
Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF: Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009, 37: e45-10.1093/nar/gkp045.
PubMed Central
CAS
PubMed
Google Scholar
Zapparoli GV, Jorissen RN, Hewitt CA, McBean M, Westerman DA, Dobrovic A: Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection. BMC Cancer. 2013, 13: 206-10.1186/1471-2407-13-206.
PubMed Central
CAS
PubMed
Google Scholar
Triche TJ, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD: Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res. 2013, 41: e90-10.1093/nar/gkt090.
PubMed Central
CAS
PubMed
Google Scholar
Maksimovic J, Gordon L, Oshlack A: SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012, 13: R44-10.1186/gb-2012-13-6-r44.
PubMed Central
PubMed
Google Scholar
Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S: A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013, 29: 189-196. 10.1093/bioinformatics/bts680.
PubMed Central
CAS
PubMed
Google Scholar
Naeem H, Wong NC, Chatterton Z, Hong MK, Pedersen JS, Corcoran NM, Hovens CM, Macintyre G: Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014, 15: 51-10.1186/1471-2164-15-51.
PubMed Central
PubMed
Google Scholar
Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, Gunderson KL: Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics. 2009, 1: 177-200. 10.2217/epi.09.14.
CAS
PubMed
Google Scholar